DataFlex Solutions is a newly formed venture of experienced pharmaceutical data management personnel. This wealth of experience has been brought together to provide high quality data management services to the industry as a whole. DataFlex Solutions’ mission is to provide high quality Clinical Data Management services at a reasonable cost. All DataFlex Solutions’ personnel have 15+ years of experience in the Clinical Research Environment. This experience extends across pharma phase I – IV, device, government grant, and investigator initiated studies. Using a dynamic, flexible, remote based model with efficient use of standards and cutting edge reporting tools, DataFlex is able to provide cost effective and innovative solutions to clients. Link
Ekteino Laboratories Inc. is a private, pre-clinical stage drug delivery company focused on developing sustained-release formulations of chronic use medications that can improve patient compliance and clinical outcomes. Our proprietary technology platform, licensed from Tufts University, is based on protein polymers that are natural components of silk, and can also be produced through recombinant DNA technology. Ekteino’s proprietary dosage forms are biocompatible, biodegradable, allow for aqueous processing, and generate no inflammatory biodegradation by-products. Our delivery toolkit includes a variety of injectable and implantable formulations, providing the potential for extended drug efficacy for small molecule drugs and biologics. Link
Sideris Pharmaceuticals is an independent biopharmaceutical company focused on the development of treatments for diseases of iron overload, including conditions involving maintenance transfusion therapy. Sideris’ lead clinical candidate, SP-420, has the potential to be the best-in-class therapeutic approach as an oral iron chelator. The company licensed the technology and lead clinical candidate from the laboratory of Prof. Ray Bergeron of the University of Florida, the pre-eminent expert on iron chelators. Link
Alnylam Pharmaceuticals has received a $7 million milestone payment from partner Genzyme Corp. for its most advanced drug for a rare, inherited heart disease, following recently-released results from a mid-stage trial. Link
2) New EMD Serono spin-off will focus on infertility treatments- Boston.com- December 2, 2013
EMD Serono Inc., a Rockland-based biopharmaceutical company with nearly 900 employees in Massachusetts, announced Monday the launch of TocopheRx, a Boston spin-off company that will focus on infertility treatments. Link
3) Biotech IPO boom likely to continue in 2014- Boston Globe- December 3, 2013
The boom in initial public offerings by biotech startups, which took many by surprise this year, looks likely to continue into 2014. But it could lose some steam if the Federal Reserve starts to withdraw the stimulus powering financial markets. Link
4) Acceleron to start trial in liver cancer patients early next year- Boston Business Journal- December 3, 2013
Newly-public biotech Acceleron Pharma says that it’s planning to start a trial of its cancer drug in patients with liver cancer early next year, based on promising early results of the same drug in kidney cancer patients. Link
5) German giant to venture into Hub- Boston Herald- December 4, 2013
The venture arm of one of the world’s largest pharmaceutical companies is opening its first U.S. office in Kendall Square, pledging to make $130 million in investments to life sciences companies. Link
Dottie Caplan works in Corporate Affairs for Sanofi. Back in May, Dottie took part in our Biotech 101 course. Here is what she had to say about the course.
Why did you decide to take Biotech 101?
The scientific advancements in biotechnology will dramatically change the healthcare landscape and, while I am not a scientist, it is critical to understand the fundamentals in order to make sense of what is happening in the industry and the implications these changes will have on the future healthcare environment.
What knowledge of biotech did you have before taking this course?
I knew bits and pieces of what is happening in the biotech world but I didn’t understand all the motivations and barriers or the strategic thinking and connectivity that would allow me to really be proactive. I am more confident and prepared to think more strategically about Biotech and what it means for the future.
What was your favorite part of the course?
The hands-on experiments really solidified the material and content of the course. The instructor was highly educated and informed and experienced the biotech world first hand. Being able to see biotech through her eyes and experience was invaluable.
What do you feel you gained from this course?
I am more strategic in my thinking and I can easily engage in a business discussion on biotech with confidence. I view events and news differently because I am able to more readily connect the dots with what is happening and understand the motivations behind the decision making and strategies being implemented.
What would you tell someone who was thinking about taking this course?
This is one of the best courses I have ever taken and you will not be disappointed. It is worth the investment of time and money. You would be hard-pressed to find a course of this caliber anywhere else.
There is still time to register for Biotech 101 on Dec 17th & 18th!
We have also announced our first spring course!
Our members are already familiar with the significant savings they see on lab supplies, office supplies and more through the MassBio Purchasing Consortium, but today we are thrilled to share that individuals at our member companies will soon see great savings too! Early next year we will launch a new Employee Perks program offering special savings and incentives at restaurants, retailers and attractions specifically for the employees of our member companies.
We have a number of companies lined up to participate, but we are looking for a few more before we launch and we need your help! Do you have any favorite local products, services or experiences you’d like to see included in the program? Are you a retailer looking to connect with the local life sciences community? Leave comments here or contact Lauren Perna at Lauren.Perna@massbio.org or 617-674-5100 to get involved!
We look forward to partnering with the retailers in our community to increase their visibility and expand their loyal customer bases while bringing the best deals out there to MassBio members – Stay tuned for the roll out in 2014!
On November 21, MassBioEd worked with Google to host a STEM Expo Night as a Kendall Square Association Third Thursday networking event. The evening celebrated STEM education efforts in the Kendall Square community, featured many fun hands-on science experiments and drew a crowd of about 100 people.
Special thanks to all of our exhibitors, to Google for hosting and providing beverages, to KSA, and to Phoodeez for their generous catering donation!
Thank you to everyone who participated! Here are some of the activities that took place: